Race and Pharmacogenomics—Personalized Medicine or Misguided Practice?
Open Access
- 16 February 2021
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 325 (7) , 625-626
Abstract
This Viewpoint uses examples of recommendations for race-based pharmacogenetic testing to discuss flaws and inconsistencies with race and ethnicity as surrogateKeywords
This publication has 4 references indexed in Scilit:
- Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical AlgorithmsNew England Journal of Medicine, 2020
- Black Kidney Function MattersJAMA, 2020
- Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug ReactionsFrontiers in Pharmacology, 2020
- Race, Ancestry, and Reporting in Medical JournalsJAMA, 2018